Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,365.02
(
-0.06%
)
US TECH 100
22,466.36
(
-0.16%
)
Dow Jones
45,333.56
(
0.37%
)
Brent Oil
107.72
(
-0.49%
)
Bitcoin
67,070.03
(
1.69%
)
News Focus
News Focus
Post# of 257308
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122821
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 245646

Wednesday, 04/19/2023 12:23:22 PM

Wednesday, April 19, 2023 12:23:22 PM

Post# of 257308
(RVNC)—FDA approves Ajinomoto’s “high potency vial line to manufacture a commercial product”:

https://www.prnewswire.com/news-releases/ajinomoto-bio-pharma-services-receives-fda-approval-for-high-potency-fill-line-301801108.html

The product in question could be Daxxify, based on the timing of the announcement.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today